June 14 Israel-based RedHill Biopharma Ltd said its experimental drug for the treatment of gastroenteritis met the main goal in a late-stage study.
The trial tested the efficacy and safety of the drug, bekinda, versus a placebo, in 321 adults and children over the age of 12.
Gastroenteritis - inflammation of the stomach and intestines that causes vomiting and diarrhea - is a very common illness in the United States, with about 179 million cases annually, the company said. (Reporting by Natalie Grover in Bengaluru)
PRECIOUS-Gold steady ahead of US data this week, weaker dollar supports
BENGALURU, June 26 Gold prices were little changed on Monday as the market waited for a flurry of key U.S. economic data this week, with a weaker dollar offering some support. FUNDAMENTALS * Spot gold was nearly flat at $1,256.06 per ounce at 0050 GMT, staying near a one-week low hit on Friday. * U.S. gold futures for August delivery rose 0.04 percent to $1,256.80 per ounce. * The dollar sagged against its major peers on Monday, los
UPDATE 1-Airbag maker Takata files for bankruptcy protection in Japan
TOKYO, June 26 Embattled airbag maker Takata Corp on Monday filed for bankruptcy protection in Japan and said it would seek $1.588 billion in financial aid from U.S.-based auto parts supplier Key Safety Systems (KSS).